Skip to contentK
Kraig Biocraft Laboratories, Inc.
K
KBLBKraig Biocraft Laboratories, Inc. Q4 2019 · 10-K
derived · Computed from the longer spans the company filed.
Revenue—
Net Income-$901.12K-$901.12KderivedN/M vs Q4 2018 EPS, diluted—Not derived. Share counts vary by quarter.
Operating Incomederived-$817,762N/M The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Kraig Biocraft Laboratories, Inc. · CIK 1413119 · Engraved from SEC EDGAR
Operating Cash Flowderived-$318,298N/M Free Cash Flowderived-$346,124N/M ended Dec 31, 2019 · filed Mar 27, 2020 · 87 d after period end